Concepedia
Statistics
Publications
12
Citations
1.2K
H-Index
11
Active since
2009
Affiliations
University of Basel(Current)
NBE Therapeutics (Switzerland)
SIB Swiss Institute of Bioinformatics
The University of Texas MD Anderson Cancer Center
Lorenz Waldmeier is an author at University of Basel specializing in molecular oncology, oncology, and life sciences.
Publications per year
2009–2024
Sox4 Is a Master Regulator of Epithelial-Mesenchymal Transition by Controlling Ezh2 Expression and Epigenetic Reprogramming
Neha Tiwari, Vijay Tiwari, Lorenz Waldmeier et al. · Cancer Cell · 2013 · 501 citations · Full text
Life Sciences, Molecular Biology, Oncology +17
The RNA-binding protein Rbfox2: an essential regulator of EMT-driven alternative splicing and a mediator of cellular invasion
Christien Braeutigam, Luciano Rago, A Rolke et al. · Oncogene · 2013 · 172 citations
Life Sciences, Genetics, Molecular Biology +12
Tead2 expression levels control Yap/Taz subcellular distribution, zyxin expression, and epithelial-mesenchymal transition
Maren Diepenbruck, Lorenz Waldmeier, Robert Ivánek et al. · Journal of Cell Science · 2014 · 131 citations · Full text
Life Sciences, Cell Biology, Molecular Biology +15
Transcription factor Dlx2 protects from TGFβ‐induced cell‐cycle arrest and apoptosis
M. Deniz Yilmaz, Dorothea Maaß, Neha Tiwari et al. · The EMBO Journal · 2011 · 77 citations · Full text
Life Sciences, Cell Biology, Molecular Biology +14
Highly Potent, Anthracycline-based Antibody–Drug Conjugates Generated by Enzymatic, Site-specific Conjugation
Nikolas Stefan, Rémy Gébleux, Lorenz Waldmeier et al. · Molecular Cancer Therapeutics · 2017 · 77 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +17
1–5 of 12